In the BioHarmony Drug Report Database
Indinavir
Crixivan (indinavir) is a small molecule pharmaceutical. Indinavir was first approved as Crixivan on 1996-03-13. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Crixivan’s patent is valid until 2021-02-10 (FDA).
Trade Name
|
Crixivan |
|---|---|
Common Name
|
indinavir |
ChEMBL ID
|
CHEMBL115 |
Indication
|
acquired immunodeficiency syndrome, hiv infections |
Drug Class
|
Antivirals: HIV protease inhibitors (saquinavir type) |
Image (chem structure or protein)